Pages that link to "Q46276350"

The following pages link to Female schizophrenia patients have prepulse inhibition deficits (Q46276350):

Displaying 28 items.

• Realistic expectations of prepulse inhibition in translational models for schizophrenia research (Q24645703) (← links)
• Improvement of prepulse inhibition and executive function by the COMT inhibitor tolcapone depends on COMT Val158Met polymorphism (Q28282922) (← links)
• Deficient prepulse inhibition in schizophrenia detected by the multi-site COGS. (Q30419989) (← links)
• Heritability of acoustic startle magnitude, prepulse inhibition, and startle latency in schizophrenia and control families (Q30474699) (← links)
• Sex-related differences in prepulse inhibition of startle in irritable bowel syndrome (IBS). (Q30475615) (← links)
• Testosterone is involved in mediating the effects of prenatal stress in male guinea pig offspring (Q30476437) (← links)
• The glutamatergic compounds sarcosine and N-acetylcysteine ameliorate prepulse inhibition deficits in metabotropic glutamate 5 receptor knockout mice (Q30481854) (← links)
• Cortical grey matter volume and sensorimotor gating in schizophrenia (Q30482440) (← links)
• Impaired prepulse inhibition and prepulse-elicited reactivity but intact reflex circuit excitability in unmedicated schizophrenia patients: a comparison with healthy subjects and medicated schizophrenia patients (Q30484437) (← links)
• Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: a double-blind, randomized controlled trial (Q30488051) (← links)
• Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures (Q30491325) (← links)
• Multi-site studies of acoustic startle and prepulse inhibition in humans: initial experience and methodological considerations based on studies by the Consortium on the Genetics of Schizophrenia (Q30494699) (← links)
• Reduced startle gating after D1 blockade: effects of concurrent D2 blockade (Q30502594) (← links)
• Brain CB₂ Receptors: Implications for Neuropsychiatric Disorders (Q33664105) (← links)
• CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity (Q36071533) (← links)
• Nicotine and nicotinic system in hypoglutamatergic models of schizophrenia (Q37059455) (← links)
• Deficient prepulse inhibition in schizophrenia in a multi-site cohort: Internal replication and extension (Q38760980) (← links)
• Prepulse inhibition in euthymic bipolar disorder patients in comparison with control subjects. (Q39688706) (← links)
• Sensorimotor gating and habituation in antipsychotic-naive, first-episode schizophrenia patients before and after 6 months' treatment with quetiapine (Q42969470) (← links)
• Effects of nicotine on quinpirole- and dizocilpine (MK-801)-induced sensorimotor gating impairments in rats (Q46496900) (← links)
• Maternal social stress modulates the development of prepulse inhibition of startle in infants. (Q46921050) (← links)
• CHRNA4 was associated with prepulse inhibition of schizophrenia in Chinese: a pilot study (Q48829372) (← links)
• Behavioral phenotyping of v-akt murine thymoma viral oncogene homolog 1-deficient mice reveals a sex-specific prepulse inhibition deficit in females that can be partially alleviated by glycogen synthase kinase-3 inhibitors but not by antipsychotics (Q50539880) (← links)
• The postweaning social isolation in C57BL/6 mice: preferential vulnerability in the male sex. (Q50801407) (← links)
• Gender differences in prepulse inhibition (PPI) in bipolar disorder: men have reduced PPI, women have increased PPI. (Q51634504) (← links)
• Long-term effects of developmental PCP administration on sensorimotor gating in male and female rats (Q51779948) (← links)
• Disruption of prepulse inhibition of the startle reflex by the preferential D(3) agonist ropinirole in healthy males. (Q51982840) (← links)
• Robust and replicable measurement for prepulse inhibition of the acoustic startle response (Q90118259) (← links)